Animal peptide toxins have become powerful tools to study structure-function relationships and physiological roles of voltage-activated Ca 2ϩ channels. In the present study, we investigated the effects of PnTx3-6, a neurotoxin purified from the venom of the spider Phoneutria nigriventer on cloned mammalian Ca 2ϩ channels expressed in human embryonic kidney 293 cells and endogenous Ca 2ϩ channels in N18 neuroblastoma cells. Whole-cell patch-clamp measurements indicate that PnTx3-6 reversibly inhibited L-(␣ 1C
136, 263, and 607 nM, respectively. Inhibition occurred without alteration of the kinetics or the voltage dependence of the exogenously expressed Ca 2ϩ channels. In N18 cells, PnTx3-6 exhibited highest potency against N-type (conotoxin-GVIAsensitive) current. In contrast to its effects on high voltageactivated Ca 2ϩ channels subtypes, application of 1 M PnTx3-6 did not affect ␣ 1G /Ca v 3.1 T-type Ca 2ϩ channels. Based on our study, we suggest that PnTx3-6 acts as a -toxin that targets high voltage-activated Ca 2ϩ channels, with a preference for the Ca v 2 subfamily (N-, P/Q-, and R-types).
Voltage-activated Ca 2ϩ channels play a major role in many physiological processes, including gene transcription, muscle contraction, release of neurotransmitters, and the regulation of neuronal excitability (Catterall, 1995; Dunlap et al., 1995) .
Furthermore, dysfunction of Ca 2ϩ channels is implicated in numerous diseases, including epilepsy, hypertension, chronic pain, migraine, and some arrhythmias (Jen, 1999; Dworakowska and Dolowy, 2000) . To find treatments for those diseases, the development of therapeutic Ca 2ϩ channel antagonists has been the subject of considerable interest (for review, see Kobayashi and Mori, 1998) . As examples, Ziconotide (or Prialt) and AM336, drugs based on the structure of -conotoxins, are currently in clinical development for chronic pain management (Schroeder et al., 2004) .
The -toxins are a family of animal peptide toxins active on Ca 2ϩ channels that have become powerful tools for the identification and isolation of Ca 2ϩ channel subtypes. The discoveries of -conotoxin GVIA, isolated from the venom of a fish-hunting cone shell mollusk and of -agatoxin IVA (-Aga-IVA), from the spider Agenelopsis aperta, aided the identification of N-type (␣ 1B /Ca v 2.2) Ca 2ϩ channels and P/Q-type (␣ 1A /Ca v 2.1) Ca 2ϩ channels, respectively (Olivera et al., 1985; McDonough et al., 2002) . Other examples include the inhibition of R-type channels (␣ 1E /Ca v 2.3) by SNX-482, a peptide isolated from the spider Hysterocrates gigas (Newcomb et al., 1998) , and the inhibition of the T-type channels (␣ 1G /Ca v 3.1 and ␣ 1H /Ca v 3.2) by a scorpion toxin, kurtoxin (Chuang et al., 1998; Sidach and Mintz, 2002) .
Toxins isolated from P. nigriventer spider venom have been extensively investigated in recent years, and electrophysiological studies indicate diverse effects of different toxins from this venom ranging from activation of Na ϩ channels to blockade of K ϩ and Ca 2ϩ channels (for review, see Gomez et al., 2002) . In the present study, we examined PnTx3-6, a member of the PhTx3 fraction (Cordeiro et al., 1993 ) that includes two other peptides that bind and inhibit HVA Ca 2ϩ channels -PnTx3-3 (Leã o et al., 2000) and -PnTx3-4, a peptide essentially identical to the HVA channel blocker -phonetoxin IIa (Cassola et al., 1998; Dos Santos et al., 2002) .
We have shown previously that PnTx3-6 inhibits K ϩ -evoked increases in [Ca 2ϩ ] and Ca 2ϩ -dependent glutamate release from synaptosomes (Vieira et al., 2003) , suggesting that the toxin targeted Ca 2ϩ channels. To characterize the interaction between PnTx3-6 and specific Ca ϩ channels as well the potency, selectivity, and possible mechanism of action of the toxin, we studied its effect on recombinant Ca 2ϩ channels heterologously expressed in human embryonic kidney (HEK) cells. Moreover, to compare results obtained with cloned Ca 2ϩ channels to native neuronal Ca 2ϩ channels, we examined the effect of the toxin on Ca 2ϩ channel currents recorded from a neuroblastoma cell line, N18 cells, which express both N-and L-type Ca 2ϩ channels (Mackie et al., 1993; Carlson et al., 1994) .
Materials and Methods
Purification of PnTx3-6. P. nigriventer venom was obtained by electrical stimulation of anesthetized spiders. Venom was centrifuged at 4000g for 10 min, and the supernatant was fractionated by gel filtration on columns of Sephadex G-50 superfine and superose 12HR, and reverse phase fast protein liquid chromatography on C 2 /C 8 (PEP-RPC) and C 1 /C 8 (PRO-RPC) columns as described in detail previously (Rezende et al., 1991; Cordeiro et al., 1993) . Peptides were detected by monitoring the absorbance at 216 nm (Cordeiro et al., 1993) . The fraction PhTx3 obtained from the chromatography on a PRO-RPC column (Rezende et al., 1991) was dissolved in 1 ml of 0.1% (v/v) aqueous trifluoroacetic acid (TFA) and subjected to reverse phase HPLC on a preparative column (22 mm ϫ 25 cm) of Vydac C18 (218TP1022; Technicol Ltd., Stockport, UK) equilibrated in the same solvent. The column was eluted with a linear gradient (0 -40% over 180 min) of acetonitrile (HPLC grade S; Rathburn Chemical Co., Peebles, Scotland, UK) in 0.1% TFA at a flow rate of 10 ml min
Ϫ1
. We collected three fractions (A-C; Cordeiro et al., 1993) , and fraction C was dissolved in 1 ml of 10 mM sodium phosphate buffer, pH 6.5, and fractionated on a weak cation exchange HPLC column (4.6 mm ϫ 25 cm) of Synchropak CM 300 (Synchrom Inc., Lafayette, IN) equilibrated in the same buffer. After absorption, the columns were eluted with a linear gradient (0 -0.5 M NaCl over 90 min) in the same buffer at a flow rate of 2 ml min Ϫ1 . The toxin PnTx3-6 eluted at a salt concentration of 0.16 M (Fig. 1) , and was desalted by absorption onto Sep-Pak C18 cartridges (Waters, Milford, MA), which were then washed with 15 ml of 0.1% TFA, and PnTx3-6 was eluted with 5 ml of acetonitrile containing 0.1% TFA. The purity of PnTx3-6 was assayed using SDS-polyacrylamide gel electrophoresis (16%) and silver staining.
Cell Culture. Human embryonic kidney cells (HEK293 tsA-201) and the neuroblastoma cell line N18 were grown in standard DMEM supplemented with 10% fetal bovine serum, 50 U ml Ϫ1 penicillin, and 50 g ml Ϫ1 streptomycin in a humidified atmosphere of 95% O 2 /5% CO 2 at 37°C. N18 cells were mechanically detached in phosphate-buffered saline containing 1 mM EDTA and plated in 35-mm culture dishes. After 1 day, N18 cells were induced to differentiate into the neuronal phenotype by reducing fetal bovine serum to 0.2% and addition of 2% dimethyl sulfoxide (Leã o et al., 2000) . The culture medium was changed every 2 days and differentiated N18 cells were used within 4 days.
Transient Transfection with L-, P/Q-, and R-Type Ca
2؉
Channels. HEK cells were grown to approximately 80% confluence, enzymatically disassociated using 0.25% trypsin in DMEM containing 1 mM EDTA (trypsin/EDTA), plated on 35-mm culture dishes at 5 to 10% confluence, and allowed to recover for 12 h. The medium was then replaced, and the cells were transiently transfected with cDNA plasmids encoding one type of Ca 2ϩ channel ␣ subunit [␣ 1A (Starr et al., 1991) , ␣ 1C (Bourinet et al., 1994) , or ␣ 1E (Soong et al., 1993) ] together with auxiliary subunits ␤ 1b and ␣ 2 ␦ (Zamponi et al., 1997) and CD8 marker plasmid at a molar ratio 1:1:1:0.25 using Lipofectamine (Invitrogen, Carlsbad, CA) following the manufacturer's instructions. After 12 h, the cells were washed with fresh medium, stored at 37°C, and allowed to recover for an additional 36 to 72 h before electrophysiology recordings. Transiently transfected cells were selected for expression of CD8 by adherence of Dynabeads (Dynal, Great Neck, NY) .
Generation of Stable Cell Lines Expressing N-and T-Type Ca 2؉ Channels. HEK cells were transfected using linearized cDNA encoding either ␣ 1G (McRory et al., 2001 ) alone or ␣ 1B (Dubel et al., 1992) together with ␤ 1b and ␣ 2 ␦ using standard Ca 2ϩ -phosphate precipitation, and clones were selected with zeocin. The stable cell lines were enzymatically dissociated using 0.25% trypsin in DMEM containing 1 mM EDTA (trypsin/EDTA), plated on 35-mm culture dishes, and allowed to recover 24 to 36 h before recordings.
Electrophysiological Recordings. Macroscopic currents were recorded using the whole-cell patch-clamp technique (Hamill et al., 1981) . Whole-cell currents were recorded using an Axopatch 200A or 200B amplifier (Axon Instruments Inc., Union City, CA), controlled and monitored with a personal computer running pClamp software (Axon Instruments Inc.). Patch pipettes were pulled from borosilicate glass using a PP-830 pipette puller (Narishige, Tokyo, Japan) and had resistances of 2 to 4 M⍀ when filled with internal solution. The internal pipette solution contained 120 mM CsCl 2 , 1 mM CaCl 2 , 11 mM EGTA, 10 mM HEPES, and 2 mM Mg-ATP, pH 7.2. The bath was connected to ground via a 3 M KCl Agar-bridge. To minimize voltage errors due to series resistances, we discarded cells with whole-cell currents Ͼ2 nA. All recordings were performed at room temperature (20 -24°C). Signals were low-pass filtered at 2 kHz and sampled at Ͼ5 KHz. In some cases, linear leak subtraction was performed using the P/4 protocol included in the Clampex program. The sample was dissolved in 1 ml of 10 mM sodium phosphate buffer, pH 6.5, and applied to a column (4.6 mm ϫ 25 cm) of the weak cation exchanger Synchropak CM 300 equilibrated in the same buffer. The column was eluted with a linear gradient of 0 to 0.5 M NaCl in the same buffer (thick line) at a flow rate of 2 ml min Ϫ1 . PnTx3-6 was eluting at a salt concentration of 0.16 M NaCl.
Novel -Toxin PnTx3-6
Recordings were analyzed using Clampfit (Axon Instruments Inc.), and off-line leak subtraction was applied to those currents that had not been subtracted on-line. Traces shown in figures were low-pass filtered at 1000 Hz for display. Statistical significance was determined by Student's t tests, and significant values were set as p Ͻ 0.01 or as indicated in the text and figure legends.
The external recording solution used to measure current through expressed Ca 2ϩ channels in HEK cells contained 2 mM BaCl 2 , 1 mM MgCl 2 , 10 mM HEPES, 40 mM tetraethylammonium-Cl, 92 CsCl, and 10 glucose, pH 7.4. For recording HVA Ca 2ϩ channel current from differentiated N18 cells, we selected round cells with very short neurites to ensure adequate space clamp. These cells often had very small Ca 2ϩ channel currents in 2 mM BaCl 2 (not shown), and to improve signal to noise, we used a high concentration of BaCl 2 compared with HEK cell recordings. The external solution for N18 recordings contained 25 mM BaCl 2 , 126 mM tetraethylammoniumCl, 10 mM HEPES, 30 mM NiCl 2 , 5.4 mM CsCl, 10 mM glucose, and 0.001 tetrodotoxin, pH 7.4.
The time course of Ba 2ϩ current inhibition by PnTx3-6 was studied using voltage steps from a holding potential of Ϫ100 mV to the peak current potentials obtained from the I-V relationship for each channel type (␣ 1A , Ϫ10 mV; ␣ 1B , ϩ10 mV; ␣ 1C , Ϫ5 mV; and ␣ 1E : Ϫ20 mV). To minimize rundown, these stimuli were applied at frequencies Ͻ0.1 Hz. Cells that did not have a stable baseline Ba 2ϩ current amplitude or that did not respond to drugs or toxin with a rapid, monophasic change in Ba 2ϩ current amplitude were not considered for analysis. Control experiments (in which control perfusion was run for several minutes) indicated that under these conditions, rundown of Ba 2ϩ currents was negligible. To construct conductance-voltage curves, the conductance (G) as a function of test potential (V test ) was calculated as
where I is the peak current generated by the step depolarization to V test , and V R is the current reversal potential determined from the I-V relationship. Deactivation was examined through analysis of tail currents after brief depolarizing steps. Steady-state inactivation curves were obtained by applying test depolarization to peak current potentials at the end of 10-s prepulses ranging in voltages from -110 to ϩ20 mV in 10-mV increments. N18 neuroblastoma cells express N-type (i.e., -conotoxin-GVIAsensitive) and L-type (i.e., dihydropyridine-sensitive) Ca 2ϩ channels (Mackie et al., 1993; Carlson et al., 1994) . We measured whole-cell Ba 2ϩ currents from these cells in the presence of 1 M tetrodotoxin to block Na ϩ channels and Ni 2ϩ (30 M) to inhibit LVA channels. Under these conditions, the fraction of total Ba 2ϩ current that was N-type was defined as that inhibited by 1 M -conotoxin-GVIA (Randall and Tsien, 1995) and will be referred to as the GVIAsensitive (GVIA-S) component. The remaining Ba 2ϩ current (resistant to -conotoxin-GVIA; GVIA) was partially inhibited by nifedipine (10 M; not shown) and increased by 5 M BayK8644 indicating, as expected (Carlson et al., 1994) , that it contained L-type current. As described under Results, we estimated inhibition of Ntype current by PnTx3-6 by comparing inhibition by PnTx3-6 of the total current (GVIA-S and GVIA-R component) with inhibition of the isolated GVIA-R component.
Solutions and Drugs. Stock solutions of PnTx3-6 were prepared in distilled water and stored at -20°C. Toxin was thawed shortly before the experiments and diluted into the bath solution at the appropriate concentration. Bovine serum albumin (0.025%; Jackson Immunoresearch Laboratories Inc., West Grove, PA) was included in all external solutions (both for experiments with HEK cells as well as N18 cells) to avoid nonspecific binding of the toxin. For experiments with expressed Ca 2ϩ channels, the perfusion system consisted of a custom-made multiple solution perfusion manifold with four input and four output capillary tubes (custom microfil, 28-gauge, 250-m inner diameter and 350-m outer diameter; WPI, Sarasota, FL) ensheathed in a glass pipette. High chemical-resistant Tygon Chemfluor FEP (Norton Performance Plastics, Akron, OH) and Silastic (Fisher Scientific, Nepean, ON, Canada) tubing was used to connect the perfusion manifold to the syringe valve. Perfusion was driven by gravity and adjusted to approximately 0.4 ml min
Ϫ1
. The outputs of the manifold were placed within proximity of the cell, resulting in rapid solution exchange times (Ͻ1 s). In experiments with N18 cells, drugs and toxins were bath applied using rapid perfusion of the bath with solution exchange times of Ͻ10 s -conotoxin-GVIA was purchased from Peptides (Osaka, Japan). All other reagents were of analytical grade. Figure 1 shows the HPLC profile of the venom fraction from which PnTx3-6 was isolated (for details, see Materials and Methods). The sequence of PnTx3-6 presents little similarity to other known peptide toxins. In Table 1 , we present the sequence of PnTx3-6 aligned with other peptide toxins exhibiting some sequence similarity and with known activity on vertebrate HVA Ca 2ϩ channels. One of these, -phonetoxin IIa, was also isolated from P. nigriventer venom and potently inhibits rat L-and N-type currents in ␤ cells and dorsal root ganglion neurons, respectively (Cassola et al., 1998) , as well as heterologously expressed P/Q-, N-, and R-type currents (Dos Santos et al., 2002) . The -Aga toxins IIIA and IIIB, which inhibit vertebrate HVA Ca 2ϩ channels (Mintz, 1994; Yan and Adams, 2000; McDonough et al., 2002) , exhibit 27% (15 amino acids) and 25% (14 amino acids) identity with PnTx3-6, respectively. Much of the identity among these toxins is due to the large number of cysteine residues, a common feature of animal peptide toxins as first described for the conotoxins (Olivera et al., 1985) .
Results

Purification and Sequence Comparison of PnTx3-6.
PnTx3-6 Selectively Blocks High Voltage-Activated Ca 2؉ Channels. Whole-cell patch-clamp recordings were performed on HEK cells transfected with cDNA coding for one type of Ca 2ϩ channel ␣ subunit (␣ 1A, ␣ 1B , ␣ 1C , or ␣ 1E ) together with ␣ 2 ␦ and ␤ 1b subunits. Figure 2 shows the dose-dependent block of the resulting Ba 2ϩ currents by PnTx3-6. The toxin produced a reversible block of all four HVA Ca 2ϩ channel subtypes tested, although the potency and rate of reversal of inhibition varied among the subtypes (Fig. 2) . The effect of PnTx3-6 was dose-dependent, with IC 50 values of 263 nM for ␣ 1A , 122 nM for ␣ 1B , 607 nM for ␣ 1C , and 136 nM for ␣ 1E . The highest concentration of PnTx3-6 used in this study (1 M) did not produce total block of ␣ 1A , ␣ 1C , or ␣ 1E channels (60, 72, and 80%, respectively; four to seven determinations). However, ␣ 1B currents were almost completely blocked (Ͼ95%) by this dose. Similar experiments were performed using cloned ␣ 1G /Ca v 3.1 channels to investigate whether the toxin had affect on LVA T-type channels; however, no effect was observed at a dose of 1 M PnTx3-6 (Supplemental Fig. 1 ). Apparent Hill coefficients were close to 1 for block of ␣ 1A , ␣ 1B , and ␣ 1E (1.6, 0.8, and 1.3, respectively). The corresponding value for ␣ 1C was 2.6, but we note that this value is poorly constrained because of the low affinity of PnTx3-6 for this channel. For the analysis of blocking kinetics that follows, we assumed a 1:1 interaction between toxin and Ca 2ϩ channel. PnTx3-6 Reversibility and Blocking Kinetics. Figure  3 shows the kinetics of block of the four HVA channel types by different concentrations of PnTx3-6. As expected for a pseudo first-order process, the time course for the development of blockade was accelerated with increasing toxin dose. At each concentration tested, the kinetic of block was well fitted by a single exponential (Fig. 3) , and the rate constant , during the application of PnTx3-6 (filled circles), and after washout of the toxin (semifilled circles). Peak currents were measured during step depolarizations from a holding potential of -100 mV to the peak current potentials obtained from the I-V relationship for each channel type (␣ 1A , Ϫ10 mV; ␣ 1B , ϩ10 mV; ␣ 1C , Ϫ5 mV; and ␣ 1E , Ϫ20 mV). The dose of toxin used in these examples was 500 nM for ␣ 1A and ␣ 1C and 100 nM for ␣ 1B and ␣ 1E . Right, dose-response curves for PnTx3-6 inhibition of HVA Ca 2ϩ channels. The smooth lines represent fits of the Hill equation:
n }, where I is the observed percentage of inhibition at a given concentration of toxin, I max is the predicted maximal inhibition, and the Hill coefficient (n) gives a measure of the steepness of the curve. Data points represent mean Ϯ S.E.M. of four to seven independent measurements. Fig. 3 . PnTx3-6 blocking kinetics in HEK 293 cells. Left, representative time courses of development and recovery from block by PnTx3-6. Currents were elicited by stepping from a holding potential of -100 mV to peak current potential (␣ 1A , Ϫ10 mV; ␣ 1B , ϩ10 mV; ␣ 1C , Ϫ5 mV; and ␣ 1E , Ϫ20 mV). In all cases, the block developed more rapidly at higher toxin concentrations. The solid lines are single exponential fits used to determine on . Right, reciprocal of the time constant for development of block is plotted versus toxin concentration. Lines represent linear regressions of the data. The slopes of the regression lines were used to estimate values of K on , and the y-intercepts to estimate values of K off . The values of K off thus obtained were 0.07, 0.1, 0.15, and 0.55 min Ϫ1 for unblock of ␣ 1A , ␣ 1B , ␣ 1C , and ␣ 1E channels, respectively.
Novel -Toxin PnTx3-6 for development of block was related linearly to toxin concentration with the slope giving a rate constant for toxin binding (K on ) of 3.13 Ϯ 0.4 M Ϫ1 min Ϫ1 (n ϭ 4; ␣ 1A ), 5.7 Ϯ 0.8 M Ϫ1 min Ϫ1 (n ϭ 5; ␣ 1B ), 4.58 Ϯ 0.15 M Ϫ1 min Ϫ1 (n ϭ 5; ␣ 1C ), and 5.4 Ϯ 0.1 M Ϫ1 min Ϫ1 (n ϭ 4; ␣ 1E ). The unblocking rate constants (K off ) were obtained from the same sets of data by extrapolating back to [PnTx3-6] ϭ 0 (Fig. 3) Table 2 ). In control, half-maximal activation occurred at Ϫ17.4 Ϯ 0.3 mV for ␣ 1A (n ϭ 8), Ϫ2.1 Ϯ 0.1 mV for ␣ 1B (n ϭ 5), Ϫ17.9 Ϯ 0.3 mV for ␣ 1C (n ϭ 6), and Ϫ30 Ϯ 1.0 mV for ␣ 1E (n ϭ 10). After reduction of the current by 50% with PnTx3-6, these parameters were unchanged: Ϫ17 Ϯ 0.5, Ϫ2.1 Ϯ 0.4, Ϫ17.2 Ϯ 0.2, and Ϫ27 Ϯ 3.0 mV, respectively; p Ͼ 0.5 for all channel types (Fig. 4) .
Steady-state inactivation of the HVA Ca 2ϩ channel types was studied by applying 10-s prepulses to different membrane potentials before a test pulse to evoke current in control, and after reduction of current by approximately 50% with PnTx3-6 (Fig. 5) . Control currents were half-inactivated by such prepulses at potentials of Ϫ63 Ϯ 0.5 (␣ 1A ; n ϭ 5), Ϫ37.5 Ϯ 1.5 (␣ 1C ; n ϭ 6), Ϫ74 Ϯ 0.5 (␣ 1E ; n ϭ 6), and Ϫ81.5 Ϯ 0.5 mV (␣ 1B ; n ϭ 7), and these values were unchanged by PnTx3-6: Ϫ62.5 Ϯ 0.4, Ϫ38 Ϯ 1.8, Ϫ74 Ϯ 0.7, and Ϫ79.6 Ϯ 1.4 mV, respectively; p Ͼ 0.5 for all channel types.
To further characterize the effect of PnTx3-6 on the kinetics of cloned Ca 2ϩ channels, we also analyzed the time constant of activation, inactivation, or deactivation of the four channels tested when the toxin was applied to the cells. Activation and inactivation rate were obtained by fitting exponentials to the rising or decaying phase of currents obtained using the voltage protocols as described for Fig. 2 . Deactivation was measured as the decay of current after return to -100 mV after a brief depolarization, as shown in Supplemental Fig. 2 . We found that current inhibition by PnTx3-6 was not accompanied by any change in Ca 2ϩ channel kinetics (Table 2 ).
PnTx3-6 Blocks N-Type Currents in N18 Cells. The results above suggest that, of the expressed Ca 2ϩ channel types tested, PnTx3-6 inhibited N-type current with the greatest potency and lowest IC 50 . Previous studies on a different toxin (kurtoxin; Chuang et al., 1998) have described discrepancies between toxin effects on expressed channels and native channels in neurons (Sidach and Mintz, 2002) . To examine inhibition of native N-type channels by PnTx3-6, we used N18 neuroblastoma cells, which express L-and N-type HVA Ca ϩ channels (Mackie et al., 1993; Carlson et al., 1994) . Na ϩ currents in these cells were blocked with 1 M tetrodotoxin, and an apparent LVA Ca 2ϩ channel current we sometimes observed was blocked with 30 M NiCl 2 (not shown). Under these conditions, PnTx3-6 (200 nM) rapidly inhibited the total whole-cell Ba 2ϩ current by 66 Ϯ 5.5% (n ϭ 10; Fig.  6A ). No run-down was observed in these cells before addition of toxin, and inhibition induced by the toxin was partially reversible (Fig. 6B) . We next measured the amount of N-type current in these cells as the fraction sensitive to inhibition by -conotoxin-GVIA (1 M; Fig. 6C ). This GVIA-S component amounted to 41 Ϯ 7.0% of the total current (Fig. 6D) . 
Ϫ1 , where G/G max is the normalized peak conductance occurring during a depolarization to the potential V, V a is the halfactivation potential, and k is the slope factor for activation. No effect of PnTx3-6 on the G-V relationship was detected for any of the four channel types tested. Results of the curve fits are given in the text.
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BayK8644 increased the remaining GVIA-R component, indicating it contained L-type current (Fig. 6C ). PnTx3-6 inhibited the GVIA-R current by 44 Ϯ 7.2%, which was less than the inhibition of the total current (compare Fig. 6 , B and E) indicating that -conotoxin-GVIA occluded part of the effect of PnTx3-6. Since PnTx3-6 blocked both the GVIA-S and GVIA-R components of the current, the total block (B T ) may be written as
where B S and B R are the amount of Block of the GVIA-S and GVIA-R components, and f S and f R are the fraction of the total current represented by each type of component. We measured B T (66%), f S (41%), B R (44%), and f R (ϭ1 Ϫ f s ; 59%), permitting calculation of B S . We conclude that 200 nM PnTx3-6 inhibits N-type currents in N18 cells by ϳ98% (Fig.  6F ). This determination is only approximate due to the uncertainty in each of the values used to solve eq. 2. Nonetheless, it seems clear that the toxin strongly inhibits the N-type currents and partially inhibits the remaining current natively expressed in N18 cells.
Discussion
PnTx3-6 Inhibition of L-, N-, R-, and P/Q-Type Currents. The present data show PnTx3-6 blockade of mammalian Ca 2ϩ channels exogenously expressed in HEK cells, whereas under the same conditions, an LVA (T-type) Ca 2ϩ channel (Ca v 3.1/␣ 1G ) was not affected. Of the four HVA Ca 2ϩ channels examined in the study, blockade by PnTx3-6 was most potent and effective on N-type (␣ 1B ) Ca 2ϩ channels (K d ϭ 17.5 nM and blockade Ͼ95%). In addition to the blockade of N-type channel, PnTx3-6 partially inhibited in a reversible manner current through ␣ 1A , ␣ 1C , and ␣ 1E channels; however, the maximal concentration applied of PnTx3-6 did not block 100% of these channels. The fact that we did not obtain complete blockade of ␣ 1A , ␣ 1C , and ␣ 1E currents may be associated with a state-dependent affinity between the channel and the toxin. As has been previously shown, a number of blockers of voltage-activated Ca 2ϩ channels display state and/or holding potential-dependent block (Bean, 1984; Kokubun et al., 1986; Feng et al., 2003; Hildebrand et al., 2004) . However, further experiments will be required to deter- 1.7 Ϯ 1.3 (7) 91.5 Ϯ 7.0 (7) 0.4 Ϯ 1.0 (7) ␣ 1B Ctrl 2.5 Ϯ 0.8 (13) 74 Ϯ 1.5 (13) 0.5 Ϯ 1.2 (13) 100 nM PnTx3-6 2.1 Ϯ 1.5 (7) 78 Ϯ 2.0 (7) 0.8 Ϯ 0.6 (8) (7) Ctrl, control. There were not significant differences between the cells and treated (p Ͼ 0.05) in all cases above.
Fig. 5.
The voltage dependence of steady-state inactivation of Ca 2ϩ channels is not affected by PnTx3-6. Cells were voltage clamped at the indicated prepulse potentials for 10 s and then stepped to the peak current potential for each channel type (␣ 1A , Ϫ10 mV; ␣ 1B , ϩ10 mV; ␣ 1C , Ϫ5 mV; and ␣ 1E , Ϫ20 mV) in control (open symbols) or during approximately 50% inhibition by PnTx3-6 (filled symbols). The toxin concentration used was 500 nM for ␣ 1A and ␣ 1C (A and C) and 100 nM for ␣ 1B and ␣ 1E (B and D) . Currents during the test pulse were normalized to the current obtained after a prepulse to -120 mV and fit with a Boltzmann equation
Ϫ1 , where G/G max is the normalized peak conductance occurring during a depolarization to the potential V, V i is the half-inactivation potential, and k is the slope factor for inactivation. No effect of PnTx3-6 on the steady-state I-V relationship was detected for any of the four channel types tested. Results of the curve fits are given in the text.
Novel -Toxin PnTx3-6 mine whether PnTx3-6 blockade depends on the channel state and/or holding potential-dependent block.
Endogenous Ca 2ϩ channel currents have been described previously in HEK cells (ISr-HEK; Berjukow et al., 1996) . Such currents were rare (15-20% of cells tested) and very small in the cells that displayed such current (0.39 pA pF Ϫ1 using 10 mM Sr 2ϩ as the charge carrier). In our experiments with HEK cells, we used 2 mM Ba 2ϩ as the charge carrier, and this lower concentration of divalent charge carrier may result in even smaller endogenous currents through any putative endogenous channels. We have occasionally seen endogenous currents in HEK cells (M. E. Hildebrand and E. Garcia, unpublished observations) . These currents were very small and rare and only seen in cell passage numbers much higher than used in this study. In contrast, we routinely observed current densities greater than 30 pA pF Ϫ1 in HEK cells transfected with Ca 2ϩ channel cDNA. Thus, endogenous currents would contribute, at most, a very minor component of the current we observed.
The time courses depicted in the Fig. 3 show the reversibility of PnTx3-6 inhibition and provide reasonable estimates of the toxin off-rate constants. Overall, the relationship 1/ on versus concentration was linear, as expected for 1:1 interaction between the channel and the toxin. The values of IC 50 obtained by fitting the dose-response data were systematically higher than the K d values obtained from analysis of the kinetics of blockade. However, the results from both methods agree that the toxin has highest affinity for ␣ 1B channels. Binding experiments could reveal which of these two values (IC 50 or K d ) is closer to the true disassociation constant for the interaction between toxin and channel.
The biophysical characterization of different channel isoforms has been successfully carried out using heterologous expression systems, e.g., HEK 293 cells or Xenopus oocytes. Whereas these systems certainly provide technical advantages, they may not fully replicate the in vivo milieu. This is evident from the fact that biophysical properties of expressed channels may differ from those seen in neurons (Sidach and Mintz, 2002) . Channels formed by ␣ 1B subunits are potently blocked by -conotoxin GVIA (Williams et al., 1992; , as are native N-type channels (Randall and Tsien, 1995) . Our results in N18 cells indicate virtually complete block of native N-type (i.e., -conotoxin GVIA-sensitive) Ca 2ϩ channels by PnTx3-6 and partial block of the GVIA-R current in these cells. Literature data suggest L-type Ca 2ϩ channels contribute to the GVIA-R component (Carlson et al., 1994) , which was supported by our observation that this current was increased by BayK8644. We could not completely block the GVIA-R component with 10 M nifedipine (not shown), which may be due to the negative holding potential used (Bean, 1984; Kokubun et al., 1986) or may indicate other channel types contributed to the GVIA-R current in our conditions. Regardless of the composition of the GVIA-R component, the data indicate that PnTx3-6 almost completely blocked the N-type, GVIA-S component, consistent with results on channels expressed in HEK cells.
PnTx3-6 Mechanism of Action. To bind to ion channels and to alter cellular function, it has been suggested that peptide toxins may act by two different mechanisms: modification of gating or pore blockade. The so-called gating modifier toxins bind close to the channel voltage sensor, and alter the voltage dependence or kinetics of gating, whereas poreblocking toxins bind to outer mouth of the channel and physically occlude the permeation pathway (McDonough et al., 2002; Sidach and Mintz, 2002 ; for review, see Doering and Zamponi, 2003) . It has been reported that -Aga-IIIA and -conotoxins (GVIA/MVIIC) partially or completely inhibit N-type Ca 2ϩ channels through pore blockade (Mintz, 1994; McDonough et al., 1996) . McDonough et al. (1996) suggest at least two distinct extracellular toxin binding site on the Ntype channel and three on the P-type Ca 2ϩ channel. There is some evidence that -agatoxin IIIA and -conotoxins GVIA/ MVIIC bind to the same site on N-and P-type channels, possibly interacting with residues in the extracellular portion of domain III S5-S6 linker (Yan and Adams, 2000) .
The broad specificity of PnTx3-6 inhibition and its blockade profile seems similar to -Aga-IIIA on HVA channels. Moreover, analysis of the sequence of PnTx3-6 in the Gen- A and B, inhibition of total whole-cell Ba 2ϩ current by PnTx3-6. A, representative Ba 2ϩ current in control and after inhibition with PnTx3-6. B, time course of inhibition of total current by PnTx3-6 (n ϭ 10 cells). C to F, separation of effect of PnTx3-6 on N-type GVIA-S and GVIA-R components of the total Ba 2ϩ current. C, representative currents recorded during sequential addition of -conotoxin-GVIA (GVIA; 1 M), BayK4866 (BayK; 5 M), and PnTx3-6 to the external solution. D, time course of inhibition of the total Ba 2ϩ current by -conotoxin-GVIA. E, time course of inhibition of the GVIA-R component of the total Ba 2ϩ current by PnTx3-6. F, observed inhibition of the total Ba 2ϩ current and the GVIA-S component and deduced inhibition of the GVIA-R component by Bank database reveals some identity with the amino acid sequence of -Aga-IIIA and -Aga-IIIB (Table 1; Cordeiro et al., 1993) . Although the molecular binding site of PnTx3-6 is unknown, our results suggest that PnTx3-6 acts in two different ways to occlude the external pore of the channels. For complete blockade of N-type currents by PnTx3-6, it seems that the toxin may bind tightly to the external mouth of the channel and physically occlude the pore. On the other hand, when PnTx3-6 is applied to P/Q-, L-, and R-type currents an incomplete blockade is reached, suggesting that the toxin might be too big to fit tightly within the outer vestibular of the pore, producing reduction of the conductance without eliminating the current flow. This effect would be similar to that described for the partial blockade of P/Q-type Ca 2ϩ channels by the peptide -Aga-IIIA (McDonough et al., 2002) . In summary, we have characterized the PnTx3-6 effects on a family of neuronal Ca 2ϩ channels. The toxin exhibited measurable preference for N-type channels among the HVA Ca 2ϩ channel subtypes tested, and blockade of this channel type was reversible. It has been shown that blockade of N-type channels has pharmacological utility to treat pain. As an example, intrathecal injection of a synthetic version of -conotoxin MVIIA has been used to block pain transmission (Wang et al., 2000) . Improved understanding of toxins may be an important advance in the development of therapeutic agents. Our results suggest that PnTx3-6 may block HVA Ca 2ϩ channels by physically occluding the channel, and we propose that PnTx3-6 may be used as a probe to study structural differences between subtypes of HVA Ca 2ϩ channels. The present results explain inhibition by this toxin of Ca 2ϩ entry and Ca 2ϩ -dependent glutamate release from isolated nerve terminals (Vieira et al., 2003) . For this reason, we suggest this toxin be referred to in the future as -PnTx3-6.
